Journal article

Cognitive and behaviour profiles of children with mucopolysaccharidosis Type II

Louise Crowe, Joy Yaplito-Lee, Vicki Anderson, Heidi Peters

COGNITIVE NEUROPSYCHOLOGY | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | Published : 2017

Abstract

Mucopolysaccharidosis Type II (MPS II) or Hunter Syndrome is a rare X-linked condition, due to a defect in a lysosomal enzyme involved in the breakdown of glycosaminoglycans. It is a progressive condition with worsening over time; however, symptom severity and progression rates vary. Normal intellectual function has been reported in males with mild MPS II but few studies are available that provide comprehensive cognitive profiles. Enzyme replacement therapy (ERT) can stabilize physical symptoms and has become standard treatment. Whether ERT can influence cognition is currently unknown. Considering this, we conducted cognitive, fine motor, and behavioural assessments with three males (7;6-12;..

View full abstract